Global changes in DNA hydroxymethlation and defective TET2 expression predict poor prognosis in chronic lymphocytic leukemia

Cristina Bagacean; Christelle Le Dantec; Amandine Charras; Anne Bordron; Yves Renaudineau

Conference Poster Year : 2015

Global changes in DNA hydroxymethlation and defective TET2 expression predict poor prognosis in chronic lymphocytic leukemia

(1, 2) , (1, 2) , (1, 2) , (1, 2) , (1, 2)

1
2

Cristina Bagacean

Function : Author

LabEX IGO Immunothérapie Grand Ouest

Immunologie et Pathologie

Christelle Le Dantec

Function : Author

LabEX IGO Immunothérapie Grand Ouest

Immunologie et Pathologie

Amandine Charras

Function : Author

LabEX IGO Immunothérapie Grand Ouest

Immunologie et Pathologie

Anne Bordron

Function : Author

LabEX IGO Immunothérapie Grand Ouest

Immunologie et Pathologie

Yves Renaudineau

Function : Author
PersonId : 4155
IdHAL : yves-renaudineau
ORCID : 0000-0001-5098-5002
IdRef : 088747263

LabEX IGO Immunothérapie Grand Ouest

Immunologie et Pathologie

CV

Domains

Immunology

Geneviève Michel : Connect in order to contact the contributor

https://hal.univ-brest.fr/hal-01269619

Submitted on : Friday, February 5, 2016-10:05:48 AM

Last modification on : Thursday, April 13, 2023-1:30:07 PM

Dates and versions

hal-01269619 , version 1 (05-02-2016)

Identifiers

HAL Id : hal-01269619 , version 1

Cite

Cristina Bagacean, Christelle Le Dantec, Amandine Charras, Anne Bordron, Yves Renaudineau. Global changes in DNA hydroxymethlation and defective TET2 expression predict poor prognosis in chronic lymphocytic leukemia. Réseau épigénétique , Oct 2015, Nantes, France. ⟨hal-01269619⟩

Global changes in DNA hydroxymethlation and defective TET2 expression predict poor prognosis in chronic lymphocytic leukemia

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Share